C-REGS 2 - Design and methodology of a high-quality comparative effectiveness observational trial

Area of Science:

• Neurology
• Clinical Research
• Pharmacology

Background:

• Acute ischemic stroke frequently results in moderate to severe neurological deficits.
• Effective treatment strategies are crucial for improving patient outcomes during rehabilitation.
• Understanding the influence of concomitant medications alongside Cerebrolysin is essential.

Purpose of the Study:

• To systematically record Cerebrolysin treatment modalities and concomitant medications in stroke patients.
• To assess the impact of these recorded parameters on therapy outcomes at day 21 and day 90.
• To evaluate the effectiveness of real-world clinical practice in stroke rehabilitation.

Main Methods:

• An open observational treatment design was employed.
• High-Quality Comparative Effectiveness Research (HQCER) principles guided the study.
• Rigorous pre-specification of analytical procedures and centralized monitoring were implemented.

Main Results:

• Data on Cerebrolysin administration and co-administered drugs were systematically collected.
• The study captured real-world therapeutic interventions for stroke patients.
• The impact of treatment variations on early and later rehabilitation outcomes was assessed.

Conclusions:

• Observational studies using HQCER can strengthen the validity of findings in real-world settings.
• This approach enhances the level of evidence for therapeutic interventions in stroke.
• The study design supports larger sample sizes and improved statistical reliability for practical application.